APEA 3P ACTUAL EXAM TEST BANK 2026/2027 |
Pathophysiology Physical Assessment Pharmacology |
Complete Questions & Answers with Rationales | Pass
Guaranteed - A+ Graded
DOMAIN 1: PATHOPHYSIOLOGY (Q1-70)
Subdomain 1A: Cellular Adaptation, Injury, Inflammation & Immunity (Q1-15)
Q1. A 58-year-old patient with chronic hepatitis develops hepatocellular swelling,
accumulation of triglycerides, and a clear vacuolated cytoplasm on liver biopsy. This
cellular adaptation represents:
A. Hypertrophy
B. Hyperplasia
C. Steatosis
D. Metaplasia
Correct Answer: C. Steatosis [CORRECT]
Rationale: Steatosis (fatty change) is characterized by intracellular accumulation of
triglycerides appearing as clear cytoplasmic vacuoles, commonly seen in hepatocytes
due to alcohol, obesity, or metabolic syndrome. Hypertrophy involves increased cell size
without division; hyperplasia involves increased cell number; metaplasia involves
conversion of one differentiated cell type to another. This biopsy demonstrates classic
macrovesicular steatosis.
Q2. A patient suffers an acute myocardial infarction. Within 24 hours, the affected
myocardium shows coagulative necrosis with preservation of cellular architecture but
loss of nuclei. Which inflammatory mediator is primarily responsible for initiating the
early neutrophilic infiltrate?
,A. Resolvin E1
B. Protectin D1
C. Interleukin-8 (IL-8)
D. Interleukin-10 (IL-10)
Correct Answer: C. Interleukin-8 (IL-8) [CORRECT]
Rationale: IL-8 is a potent neutrophil chemoattractant released by macrophages and
endothelial cells early in acute inflammation, driving neutrophil margination and
extravasation to clear necrotic debris. Resolvins and protectins are pro-resolving
mediators that terminate inflammation, not initiate it. IL-10 is anti-inflammatory and
suppresses neutrophil recruitment.
Q3. A 45-year-old woman presents with bilateral hand stiffness, Raynaud phenomenon,
and anti-centromere antibodies. She is diagnosed with limited cutaneous systemic
sclerosis. The pathophysiology of her fibrosis involves which key cytokine?
A. Interleukin-1 (IL-1)
B. Transforming growth factor-beta (TGF-β)
C. Tumor necrosis factor-alpha (TNF-α)
D. Interferon-gamma (IFN-γ)
Correct Answer: B. Transforming growth factor-beta (TGF-β) [CORRECT]
Rationale: TGF-β is the master regulator of fibrosis, stimulating fibroblasts to
differentiate into myofibroblasts and deposit collagen in systemic sclerosis. While
TNF-α and IL-1 contribute to inflammation, TGF-β directly drives the fibrotic cascade.
IFN-γ typically antagonizes fibrosis and is more associated with Th1 immune
responses.
Q4. A patient with HIV/AIDS has a CD4 count of 180 cells/µL and develops
Pneumocystis jirovecii pneumonia. Which pathophysiologic concept explains why viral
eradication is not achieved despite antiretroviral therapy?
A. Viral mutation rate only
,B. Latent viral reservoirs in resting CD4+ T cells
C. Complete immune reconstitution
D. Antibody-dependent cellular cytotoxicity failure
Correct Answer: B. Latent viral reservoirs in resting CD4+ T cells [CORRECT]
Rationale: HIV establishes latent infection in long-lived resting memory CD4+ T cells
and other sanctuary sites, forming viral reservoirs that persist despite suppressive ART.
These reservoirs are the primary barrier to cure and are targets of latency reversal
agents in 2026 research. Viral mutation drives resistance but not persistence; immune
reconstitution is incomplete in advanced HIV.
Q5. A 62-year-old man with Graves disease has TSH receptor antibodies stimulating
thyroid hormone production. This represents which type of hypersensitivity reaction?
A. Type I
B. Type II
C. Type III
D. Type V
Correct Answer: D. Type V [CORRECT]
Rationale: The 2026/2027 updated classification includes Type V hypersensitivity as
receptor-mediated autoimmune disease where antibodies stimulate or block cell
surface receptors, including Graves disease (TSH receptor stimulation) and myasthenia
gravis (acetylcholine receptor blockade). Type II involves antibody-mediated
cytotoxicity; Type V specifically denotes receptor-mediated functional stimulation.
Q6. A patient with systemic lupus erythematosus has immune complex deposition in
the glomerular basement membrane causing complement activation and neutrophil
recruitment. This represents:
A. Type I hypersensitivity
B. Type II hypersensitivity
C. Type III hypersensitivity
, D. Type IV hypersensitivity
Correct Answer: C. Type III hypersensitivity [CORRECT]
Rationale: Type III hypersensitivity involves circulating immune complex deposition in
tissues (glomeruli, skin, joints) with complement activation and neutrophilic infiltration,
characteristic of SLE nephritis. Type I is IgE-mediated; Type II is antibody-mediated
cytotoxicity against cell surface antigens; Type IV is T-cell mediated delayed
hypersensitivity.
Q7. A 55-year-old man with chronic alcohol use presents with painless jaundice and an
elevated IgG4 level. Imaging reveals diffuse pancreatic enlargement. Which emerging
autoimmune condition should be suspected?
A. Primary biliary cholangitis
B. IgG4-related disease
C. Autoimmune hepatitis type 1
D. Primary sclerosing cholangitis
Correct Answer: B. IgG4-related disease [CORRECT]
Rationale: IgG4-related disease is an emerging fibroinflammatory condition
characterized by tumefactive lesions, dense lymphoplasmacytic infiltrate rich in IgG4+
plasma cells, and elevated serum IgG4, affecting pancreas (type 1 autoimmune
pancreatitis), salivary glands, and bile ducts. It is distinct from other autoimmune
hepatobiliary diseases and responds to glucocorticoids.
Q8. A patient with sepsis develops acute kidney injury. Which 2026 KDIGO biomarker is
most specific for tubular damage and rises earlier than creatinine?
A. Serum creatinine
B. Blood urea nitrogen
C. Neutrophil gelatinase-associated lipocalin (NGAL)
D. Serum cystatin C
Pathophysiology Physical Assessment Pharmacology |
Complete Questions & Answers with Rationales | Pass
Guaranteed - A+ Graded
DOMAIN 1: PATHOPHYSIOLOGY (Q1-70)
Subdomain 1A: Cellular Adaptation, Injury, Inflammation & Immunity (Q1-15)
Q1. A 58-year-old patient with chronic hepatitis develops hepatocellular swelling,
accumulation of triglycerides, and a clear vacuolated cytoplasm on liver biopsy. This
cellular adaptation represents:
A. Hypertrophy
B. Hyperplasia
C. Steatosis
D. Metaplasia
Correct Answer: C. Steatosis [CORRECT]
Rationale: Steatosis (fatty change) is characterized by intracellular accumulation of
triglycerides appearing as clear cytoplasmic vacuoles, commonly seen in hepatocytes
due to alcohol, obesity, or metabolic syndrome. Hypertrophy involves increased cell size
without division; hyperplasia involves increased cell number; metaplasia involves
conversion of one differentiated cell type to another. This biopsy demonstrates classic
macrovesicular steatosis.
Q2. A patient suffers an acute myocardial infarction. Within 24 hours, the affected
myocardium shows coagulative necrosis with preservation of cellular architecture but
loss of nuclei. Which inflammatory mediator is primarily responsible for initiating the
early neutrophilic infiltrate?
,A. Resolvin E1
B. Protectin D1
C. Interleukin-8 (IL-8)
D. Interleukin-10 (IL-10)
Correct Answer: C. Interleukin-8 (IL-8) [CORRECT]
Rationale: IL-8 is a potent neutrophil chemoattractant released by macrophages and
endothelial cells early in acute inflammation, driving neutrophil margination and
extravasation to clear necrotic debris. Resolvins and protectins are pro-resolving
mediators that terminate inflammation, not initiate it. IL-10 is anti-inflammatory and
suppresses neutrophil recruitment.
Q3. A 45-year-old woman presents with bilateral hand stiffness, Raynaud phenomenon,
and anti-centromere antibodies. She is diagnosed with limited cutaneous systemic
sclerosis. The pathophysiology of her fibrosis involves which key cytokine?
A. Interleukin-1 (IL-1)
B. Transforming growth factor-beta (TGF-β)
C. Tumor necrosis factor-alpha (TNF-α)
D. Interferon-gamma (IFN-γ)
Correct Answer: B. Transforming growth factor-beta (TGF-β) [CORRECT]
Rationale: TGF-β is the master regulator of fibrosis, stimulating fibroblasts to
differentiate into myofibroblasts and deposit collagen in systemic sclerosis. While
TNF-α and IL-1 contribute to inflammation, TGF-β directly drives the fibrotic cascade.
IFN-γ typically antagonizes fibrosis and is more associated with Th1 immune
responses.
Q4. A patient with HIV/AIDS has a CD4 count of 180 cells/µL and develops
Pneumocystis jirovecii pneumonia. Which pathophysiologic concept explains why viral
eradication is not achieved despite antiretroviral therapy?
A. Viral mutation rate only
,B. Latent viral reservoirs in resting CD4+ T cells
C. Complete immune reconstitution
D. Antibody-dependent cellular cytotoxicity failure
Correct Answer: B. Latent viral reservoirs in resting CD4+ T cells [CORRECT]
Rationale: HIV establishes latent infection in long-lived resting memory CD4+ T cells
and other sanctuary sites, forming viral reservoirs that persist despite suppressive ART.
These reservoirs are the primary barrier to cure and are targets of latency reversal
agents in 2026 research. Viral mutation drives resistance but not persistence; immune
reconstitution is incomplete in advanced HIV.
Q5. A 62-year-old man with Graves disease has TSH receptor antibodies stimulating
thyroid hormone production. This represents which type of hypersensitivity reaction?
A. Type I
B. Type II
C. Type III
D. Type V
Correct Answer: D. Type V [CORRECT]
Rationale: The 2026/2027 updated classification includes Type V hypersensitivity as
receptor-mediated autoimmune disease where antibodies stimulate or block cell
surface receptors, including Graves disease (TSH receptor stimulation) and myasthenia
gravis (acetylcholine receptor blockade). Type II involves antibody-mediated
cytotoxicity; Type V specifically denotes receptor-mediated functional stimulation.
Q6. A patient with systemic lupus erythematosus has immune complex deposition in
the glomerular basement membrane causing complement activation and neutrophil
recruitment. This represents:
A. Type I hypersensitivity
B. Type II hypersensitivity
C. Type III hypersensitivity
, D. Type IV hypersensitivity
Correct Answer: C. Type III hypersensitivity [CORRECT]
Rationale: Type III hypersensitivity involves circulating immune complex deposition in
tissues (glomeruli, skin, joints) with complement activation and neutrophilic infiltration,
characteristic of SLE nephritis. Type I is IgE-mediated; Type II is antibody-mediated
cytotoxicity against cell surface antigens; Type IV is T-cell mediated delayed
hypersensitivity.
Q7. A 55-year-old man with chronic alcohol use presents with painless jaundice and an
elevated IgG4 level. Imaging reveals diffuse pancreatic enlargement. Which emerging
autoimmune condition should be suspected?
A. Primary biliary cholangitis
B. IgG4-related disease
C. Autoimmune hepatitis type 1
D. Primary sclerosing cholangitis
Correct Answer: B. IgG4-related disease [CORRECT]
Rationale: IgG4-related disease is an emerging fibroinflammatory condition
characterized by tumefactive lesions, dense lymphoplasmacytic infiltrate rich in IgG4+
plasma cells, and elevated serum IgG4, affecting pancreas (type 1 autoimmune
pancreatitis), salivary glands, and bile ducts. It is distinct from other autoimmune
hepatobiliary diseases and responds to glucocorticoids.
Q8. A patient with sepsis develops acute kidney injury. Which 2026 KDIGO biomarker is
most specific for tubular damage and rises earlier than creatinine?
A. Serum creatinine
B. Blood urea nitrogen
C. Neutrophil gelatinase-associated lipocalin (NGAL)
D. Serum cystatin C
